Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
58 participants
INTERVENTIONAL
2016-11-30
2018-08-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Brief Cognitive Behavioral Therapy (CBT) for Pediatric Anxiety and Depression in Primary Care
NCT01147614
Computer-assisted Cognitive-Behavior Therapy for Depression in Primary Care
NCT02700009
Cognitive Behavioral Therapy for Treatment of Adult Attention Deficit Hyperactivity Disorder
NCT00118911
Cell Phone-supported Cognitive Behavioural Therapy
NCT01205191
Computerized Cognitive Behavioral Therapy and Electroconvulsive Therapy
NCT02176473
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
OTHER
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Standard treatment as usual (TAU)
Treatment normally offered at this primary care clinic
No interventions assigned to this group
TAU plus CBT4CBT program
Treatment normally offered at this clinic PLUS 8 weeks of CBT4CBT computerized therapy.
Standard Treatment As Usual (TAU)
Treatment normally offered at this primary care clinic
CBT4CBT program
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Standard Treatment As Usual (TAU)
Treatment normally offered at this primary care clinic
CBT4CBT program
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Are applying for outpatient substance abuse treatment
* Meet current DSM-IV criteria for cocaine, marijuana, opioid, alcohol or other stimulant use disorder
* Are sufficiently stable for 8 weeks of outpatient treatment
* Can commit to 8 weeks of treatment and are willing to be randomized to treatment
* Are willing to provide locator information.
Exclusion Criteria
* Have a current legal case pending such that incarceration during the 8 week protocol is likely
* Are in need of detoxification from alcohol, opioids or benzodiazepines
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
National Institute on Drug Abuse (NIDA)
NIH
Yale University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Kathleen M Carroll, PhD
Role: PRINCIPAL_INVESTIGATOR
Yale University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Yale New Haven Hospital St Raphael's Campus
New Haven, Connecticut, United States
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Tetrault JM, Holt SR, Cavallo DA, O'Connor PG, Gordon MA, Corvino JK, Nich C, Carroll KM. Computerized Cognitive Behavioral Therapy for Substance Use Disorders in a Specialized Primary Care Practice: A Randomized Feasibility Trial to Address the RT Component of SBIRT. J Addict Med. 2020 Dec;14(6):e303-e309. doi: 10.1097/ADM.0000000000000663.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
1607018152
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.